Company intelligence / Profile preview

GeneMedicine Co., Ltd.

Hanam-si, Gyeonggi-do, South Koreapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~50
Development stage: Phase 1

Overview

GeneMedicine has demonstrated promising preclinical data and early clinical results for its lead programs. GM101 completed a phase I trial with an excellent safety profile in triple negative breast cancer; GM103 is in a phase 1/2 basket trial targeting multiple solid tumors. The company is preparing additional candidates for clinical development. Their approach aims to overcome limitations of conventional oncolytic virotherapy through proprietary vector engineering.[3][6]

Therapeutic areas: Oncology
Modalities: Oncolytic viruses (primarily oncolytic adenovirus)Gene therapy vectors[5][6]
Industry: Biotech

Drug pipeline

4 assets

GM-103

3 more assets in the full pipeline.

Request access →

Partnerships

Licensing agreements with US NASDAQ-listed companies ("F" and "M", names not specified)[1]CDMO contract with WuXi AppTec[1]

Beyond the preview

Go deeper on GeneMedicine Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneMedicine Co., Ltd..

Explore the full profile